- Androgen receptor and male infertility2005 | Third Faculty of Medicine, Central Library of Charles University
- Up-to-date insight into significance of gene mutation for androgenic receptor in the pathogenesis of prostate cancer2004 | Third Faculty of Medicine
- Clonal nature of sclerosing polycystic adenosis of salivary glands demonstrated by using the polymorphism of the human androgen receptor (HUMARA) locus as a marker2006 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Darolutamide2021 | First Faculty of Medicine
- Darolutamide in the treatment of metastatic castrate-resistant prostate cancer2022 | First Faculty of Medicine
- Surprising diagnosis of a rare endocrine disease when examining a child for short stature2014 | Faculty of Medicine in Pilsen
- Enzalutamide and abiraterone in the treatment of patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy2023 | First Faculty of Medicine
- Enzulutamide in treatment in patients with metastatic castration-resistant prostate cancer after previous chemotherapy2017 | First Faculty of Medicine
- Androgen insensitivity syndrome - case report2014 | Faculty of Medicine in Pilsen
- The first experience with darolutamid in the treatment of prostate cancer2021 | First Faculty of Medicine
- Cystic Hypersecretory Carcinoma: Rare and Potentially Aggressive Variant of Intraductal Carcinoma of the Breast. Report of Five Cases2005 | First Faculty of Medicine
- Účinnost enzalutamidu v léčbě metastatického kastračně rezistentního karcinomu prostaty2020 | First Faculty of Medicine
- The androgen receptor and prostate cancer2005 | Third Faculty of Medicine
- Non-metastatic castration-resistant prostate cancer and darolutamide - is there anything extra?2021 | Faculty of Medicine in Pilsen
- Utilization of X-Chromosome Inactivation Assessment2003 | First Faculty of Medicine
- Trends in the treatment of metastatic castration-sensitive prostate cancer2023 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Abirateron acetate2017 | First Faculty of Medicine
- Enzalutamide in treatment of the metastatic castrate resistant prostate cancer2019 | First Faculty of Medicine
- The role of ARTA in metastatic hormon-naive prostate cancer treatment2022 | Third Faculty of Medicine
- ARTA treatment of metastatic castration-resistant prostate cancer - case report2021 | First Faculty of Medicine
- Triplet in the treatment of hormone-sensitive prostate cancer2023 | First Faculty of Medicine
- Prostate cancer - cardiac complications of treatment2021 | First Faculty of Medicine
- Zkušenosti s léčbou abirateronem u pacienta s karcinomem prostaty2020 | First Faculty of Medicine
- LATITUDE study and current perspectives in the treatment of metastatic, hormone-sensitive prostate cancer2020 | Third Faculty of Medicine
- Treatment of lung metastases in prostate cancer - case reports2021 | Third Faculty of Medicine
- Treatment of non‐metastatic castration‐resistant prostate cancer2023 | Third Faculty of Medicine
- Studie FIGARO-DKD2021 | First Faculty of Medicine
- Sarcopenia as a severe organ failure, its diagnosing and present therapeutic possibilities2018 | First Faculty of Medicine
- MicroRNA in Prostate Cancer2012 | Faculty of Medicine in Pilsen
- Isoflavons in the medicine. Clinical experience2008 | Third Faculty of Medicine